Akero Therapeutics Inc (NASDAQ:AKRO) shares, rose in value, with the stock price up by 5.98% to the previous day’s close as strong demand from buyers drove the stock to $48.03.
Actively observing the price movement in the last trading, the stock closed the session at $45.32. Referring to stock’s 52-week performance, its high was $58.40, and the low was $17.86. On the whole, AKRO has fluctuated by 11.59% over the past month.
With the market capitalization of Akero Therapeutics Inc currently standing at about $3.83 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AKRO’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of AKRO currently trading nearly 10.52% and 15.53% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.65, while the 7-day volatility ratio is showing 4.68% which for the 30-day chart, stands at 6.27%. Furthermore, Akero Therapeutics Inc (AKRO)’s beta value is -0.20, and its average true range (ATR) is 3.05.
A comparison of Akero Therapeutics Inc (AKRO) with its peers suggests the former has fared considerably weaker in the market. AKRO showed an intraday change of 5.98% in last session, and over the past year, it grew by 162.17%%.
Data on historical trading for Akero Therapeutics Inc (NASDAQ:AKRO) indicates that the trading volumes over the past 3 months, they’ve averaged 1.36 million. According to company’s latest data on outstanding shares, there are 79.67 million shares outstanding.
Nearly 10.06% of Akero Therapeutics Inc’s shares belong to company insiders and institutional investors own 102.10% of the company’s shares. The stock has risen by 72.65% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AKRO stock heading into the next quarter.
